On November 8, 2018 Brookfield Asset Management (BAM) released Q3 and YTD2018 results. $1.1B of Funds from Operations (FFO) were generated during Q3 versus $0.8B in Q3 2017. It has raised $12B of capital since the end of Q2 and it is now in the midst of raising capital across all three flagship funds. It [...]
Summary Becton Dickinson released its Q4 and FY2018 results and FY2019 Guidance on November 6th. Integration of Carefusion and C.R. Bard is proceeding as planned and management expects strong underlying growth of approximately 16% - 17% on a currency-neutral basis which is in excess of the C.R. Bard deal model. BDX expects to deliver adjusted [...]
On November 6, 2018 Becton Dickinson (BDX) released Q4 and FY2018 results and provided guidance for FY2019. BDX is making good progress with the integration of Carefusion and C.R. Bard. Management is committed to deleveraging the Balance Sheet to below 3x over 3 years and $1.2B of debt was repaid in FY2018 which is slightly [...]
On November 6, 2018 Broadridge (BR) released Q1 2019 results and reaffirmed FY2019 guidance which it has provided at the time of its release of FY2018 financials on August 7, 2018. In my previous BR article I viewed shares as expensive and suggested investors patiently for a better entry point. Following the release of Q1 [...]
Summary BR shares dropped ~9.7% upon the November 6, 2018 release of good Q1 2019 results and the reaffirmation of encouraging FY2019 projections. In my August 7th article I indicated I was of the opinion that BR shares were overvalued and that investors should wait for BR shares to pullback. BR’s FY2017 – FY2020 growth [...]
During my journey to financial freedom I have continually strived to invest in high quality companies. In this post I disclose all the companies in which shares are currently held in the FFJ Portfolio and in undisclosed accounts. This is an updated from my October 9, 2018 post. Subsequent to my October 9, 2018 [...]
Not all investment decisions are made solely on a company's financial performance. In the case of my long-term investment in Philip Morris (PM), I no longer am willing to accept that I have invested in a company which provides no benefit to society. I have decided to liquidate my shares in Philip Morris and to [...]
On August 27, 2015 I initiated an 'experiment' to determine which company would generate the best investment returns over a 20+ year time frame - Chevron (CVX) or Exxon Mobil (XOM). As at November 3, 2018, the value of my current CVX holdings is ~$10,000 greater than the value of the XOM holdings; dividends are [...]
On November 2, 2018, Enbridge (ENB) released solid Q3 2018 results and provided an update on its strategic initiatives. ENB is heavily leveraged but once it completes its secured growth project inventory I envision ENB generating significant Free Cash Flow which can be used to reduce debt and support continued low double digit percentage growth [...]
Summary Enbridge released its Q3 results on November 2nd in which it reported a GAAP loss of $0.09B or ($0.05)/share for Q3. This included the impact of a number of unusual, non-recurring or non-operating factors. Q3 Distributable Cash Flow (DCF) was $1.585B versus $1.334B for Q3 2017. Management reaffirmed FY2018 financial guidance with the DCF/share [...]
